Three Swedish Stocks Estimated To Be Trading Below Intrinsic Value

In This Article:

As global markets respond to China's stimulus measures and European indices show signs of recovery, Sweden's economic landscape is also experiencing shifts, highlighted by the Riksbank's recent interest rate cut. In this context, investors are increasingly looking for opportunities in stocks that may be trading below their intrinsic value, offering potential for growth as market conditions stabilize. Identifying such undervalued stocks involves assessing factors like strong fundamentals and resilience amidst current economic trends.

Top 10 Undervalued Stocks Based On Cash Flows In Sweden

Name

Current Price

Fair Value (Est)

Discount (Est)

CTT Systems (OM:CTT)

SEK268.00

SEK493.60

45.7%

Concentric (OM:COIC)

SEK217.00

SEK406.77

46.7%

Biotage (OM:BIOT)

SEK184.70

SEK363.63

49.2%

Lindab International (OM:LIAB)

SEK279.20

SEK528.97

47.2%

Nolato (OM:NOLA B)

SEK52.10

SEK98.69

47.2%

Mentice (OM:MNTC)

SEK27.20

SEK51.00

46.7%

Tourn International (OM:TOURN)

SEK8.82

SEK16.49

46.5%

Nexam Chemical Holding (OM:NEXAM)

SEK4.07

SEK7.92

48.6%

MilDef Group (OM:MILDEF)

SEK84.50

SEK160.69

47.4%

Lyko Group (OM:LYKO A)

SEK116.80

SEK217.24

46.2%

Click here to see the full list of 44 stocks from our Undervalued Swedish Stocks Based On Cash Flows screener.

Underneath we present a selection of stocks filtered out by our screen.

Biotage

Overview: Biotage AB (publ) offers solutions and products for drug discovery and development, analytical testing, and water and environmental testing, with a market cap of SEK 14.84 billion.

Operations: The company's revenue segments include Healthcare Software, which generated SEK 2.08 billion.

Estimated Discount To Fair Value: 49.2%

Biotage is trading at SEK184.7, significantly below its estimated fair value of SEK363.63, suggesting it is undervalued based on discounted cash flows. Earnings are projected to grow 20.4% annually, outpacing the Swedish market's 15.2% growth forecast, while revenue is expected to increase by 11.1%. Recent executive changes with Frederic Vanderhaegen as CEO and M&A rumors involving KKR's stake add strategic interest amidst strong financial performance in recent quarters.

OM:BIOT Discounted Cash Flow as at Oct 2024
OM:BIOT Discounted Cash Flow as at Oct 2024

Fortnox

Overview: Fortnox AB (publ) offers financial and administrative software solutions for small and medium-sized businesses, accounting firms, and organizations, with a market cap of approximately SEK38.55 billion.

Operations: The company's revenue is derived from various segments including Core Products (SEK734 million), Businesses (SEK378 million), Accounting Firms (SEK352 million), Marketplaces (SEK160 million), and Financial Services (SEK249 million).